20 However, in our study, after a follow-up of ≥5 years, a clear trend between the incidence of GC-related diseases and cumulative GC dose was not seen for comorbid diseases other than diabetes mellitus.
← all excerpts
Real-world glucocorticoid prescription patterns in patients with lupus nephritis: A retrospective study using a healthcare insurance claims database.
1
—
—